Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP479967.RAX4U_m5Ev083EdlhnZUMpMRRESuqYx1NjxZY18ymwqtI130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479967.RAX4U_m5Ev083EdlhnZUMpMRRESuqYx1NjxZY18ymwqtI130_provenance.
• NP297910.RAAzSeCkHJlWHuVJhry1eKUwEapcOuVVbxRFBngKcOeSM130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297910.RAAzSeCkHJlWHuVJhry1eKUwEapcOuVVbxRFBngKcOeSM130_provenance.
• NP677475.RA6XqZq9V827SrZPCWpJ-7BeJDrwRy7tUiuWnmIlQ1J20130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677475.RA6XqZq9V827SrZPCWpJ-7BeJDrwRy7tUiuWnmIlQ1J20130_provenance.
• NP859232.RA5fVa9TBG4_jPLZk3O7JgVL0mKX5kW00dPn-9A8eyDmM130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859232.RA5fVa9TBG4_jPLZk3O7JgVL0mKX5kW00dPn-9A8eyDmM130_provenance.
• NP297874.RAYcf5sVEhoDmq9QtNFJTy4Piz2rD_PqjIm4Tghvtm11Y130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297874.RAYcf5sVEhoDmq9QtNFJTy4Piz2rD_PqjIm4Tghvtm11Y130_provenance.
• NP1054630.RAAnQo-qQ5FYjoPpvCTACRlMV_ToDm06ovs3UGWP1c31I130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1054630.RAAnQo-qQ5FYjoPpvCTACRlMV_ToDm06ovs3UGWP1c31I130_provenance.
• assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP297928.RAku9F-5PFpd2CFsrv7p7mY2mA6UhfDiIzlHyVB9BKe-U130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297928.RAku9F-5PFpd2CFsrv7p7mY2mA6UhfDiIzlHyVB9BKe-U130_provenance.
• NP1054628.RAtvjyeLrFN-5V8UZMudGwiVEFr22qN85D8hA7r7pBG6g130_assertion description "[CD74 is a suitable target for ADCs in some solid tumor xenografts, with efficacy largely influenced by uniformity of CD74 expression and with SN-38 conjugates providing the best therapeutic responses; SN-38 conjugates were preferable in solid cancers, whereas doxorubicin ADC was better in lymphoma tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1054628.RAtvjyeLrFN-5V8UZMudGwiVEFr22qN85D8hA7r7pBG6g130_provenance.